Smartleaf Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Smartleaf Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$1.77K	–	3527
2025 Q4	$1.77K	Buy	+8	New	+$1.29K	﹤0.01%	3021

Smartleaf Asset Management's CDTX Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 8 shares — an estimated $1.77K sold.

Smartleaf Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.77K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Smartleaf Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Smartleaf Asset Management sold 8 Cidara Therapeutics shares in Q1 2026, an estimated $1.77K.
Smartleaf Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Smartleaf Asset Management's Cidara Therapeutics position peaked at $1.77K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.